DDF MATTIFYING OIL CONTROL UV MOISTURIZER SPF 15
-
avobenzone,
ensulizole,
octisalate and
octocrylene lotion
Procter & Gamble Manufacturing Co.
Disclaimer: Most OTC drugs are not reviewed and approved by FDA, however they may be marketed if they comply with applicable regulations and policies. FDA has not evaluated whether this product complies.
----------
Sun Alert: Limiting sun exposure, wearing protective clothing, and using sunscreens may reduce the risks of skin aging, skin cancer and other harmful effects of the sun.
water, polyethylene, glycerin, dimethicone, triethanolamine, isopropyl isostearate, pentylene glycol, panthenol, tocopheryl acetate, sodium dehydroacetate, propylene glycol, hamamelis virginiana (witch hazel) extract, calendula officinalis flower extract, aloe barbadensis leaf juice, zingiber officinale (ginger) root extract, retinyl palmitate, lactic acid, benzyl alcohol, silica dimethicone silylate, stearyl alcohol, behenyl alcohol, acrylates/C10-30 alkyl acrylate crosspolymer, cetyl alcohol, hydroxyethylcellulose, dimethiconol, PEG-100 stearate, cetearyl glucoside, cetearyl alcohol, carbomer, disodium EDTA, PEG-4 laurate, PEG-4 dilaurate, sodium hyaluronate, PEG-4, iodopropynyl butylcarbamate, trideceth-9, sodium benzoate, PEG-40 hydrogenated castor oil, potassium sorbate, ethylparaben, methylparaben, propylparaben.
DDF®
DOCTOR'S DERMATOLOGIC FORMULA
MATTIFYING
OIL CONTROL
UV MOISTURIZER
SPF 15
PROTECT
ACNE
NET WT. 1.7 OZ. e 48 g
DDF
MATTIFYING OIL CONTROL UV MOISTURIZER SPF 15
avobenzone, ensulizole, octisalate, octocrylene lotion |
||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
|
||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
|
||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
|
||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
|
||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
|
Marketing Information | |||
Marketing Category | Application Number or Monograph Citation | Marketing Start Date | Marketing End Date |
OTC monograph not final | part352 | 11/01/2009 | 06/15/2011 |
Labeler - Procter & Gamble Manufacturing Co. (004238200) |
Revised: 09/2011 Procter & Gamble Manufacturing Co.